Skip to main content
. 2014 Aug 18;9(8):e104953. doi: 10.1371/journal.pone.0104953

Table 2. Univariate and multivariable associations to 30-day overall survival in 160 septic shock patients.

Univariate Cox models Multivariable Cox Model 1c (main effects model; N = 152) Multivariable Cox Model 2d (“interaction” model; N = 152)
Prognostic Variablea Units Nb HR (95%CI) p-value HR (95%CI) p-value HR (95%CI) p-value
NFKB1 promoter polymorphism genotype II 65 1 0.03 1 0.003
ID/DD 95 1.91 (1.08;3.36) 2.59 (1.39;4.82)
Hydrocortison therapy without HC 56 104 1 0.02 1 0.005
with HC 2.15 (1.16;3.98) 2.64 (1.33;5.23)
NFKB1 promoter polymorphism genotype and HC therapy II with HC 45 1 <0.0001e 1 <0.0001e
II without HC 20 1.03 (0.36;2.97) 0.74 (0.20;2.70)
ID/DD with HC 59 3.18 (1.61;6.28) 3.52 (1.72;7.22)
ID/DD without HC 36 0.92 (0.37;2.97) 1.06 (0.42;2.70)
Agea per 5 years 160 1.00 (0.92;1.08) 0.92
< 57 years 77 1 0.53
≥ 57 years 83 0.85 (0.51;1.42)
Sex Female 59 1 0.21
Male 101 0.71 (0.43;1.20)
Height per cm 130 1.00 (0.98;1.03) 0.92
Body weight per kg 131 1.00 (0.99;1.02) 0.49
Body-mass-index per kg/m2 129 1.01 (0.97;1.06) 0.55
Arterial pressure per mmHg 160 0.98 (0.97;1.00) 0.12 0.98 (0.96;1.00) 0.09 0.98 (0.96;1.00) 0.07
Noradrenaline dosage per mg/h 160 1.01 (0.97;1.06) 0.67
Creatinin serum- concentration per mg/dl 151 1.14 (0.89;1.47) 0.29
Dialysis no 57 1 0.09 1 0.51 1 0.54
Yes 95 1.65 (0.92;2.95) 1.22 (0.67;2.23) 1.21 (0.66;2.20)
SAPS II per point 160 1.01 (1.00;1.03) 0.18
SOFA per point 111 1.06 (0.98;1.15) 0.15
Pro-calcitonin concentration per µg/l 145 1.00 (1.00;1.01) 0.26
C-reactive protein concentration per g/l 145 1.01 (0.98;1.03) 0.56
Blood leukocyte concentration per n/l 156 1.00 (0.98;1.03) 0.88
a

Multivariable Cox regression analysis for continuous prognostic variables are displayed for the continuous linear predictor; for “Age” we performed several sensitivity analyses including those displayed, in addition to a combined linear and quadratic continuous predictor – these transformations had no impact on the conclusions.

b

the number of available data for a particular variable in the univariate analysis.

c

model in which all main effects of potential prognostic factors with univariate uncorrected p-values < 0.15 are included.

d

like model 1 (see c) but main effects of NFKB1 genotype and hydrocortisone therapy are included as four subgroup.